Stocks making the biggest moves premarket: Nvidia, HP, Salesforce, Dollar General, Everpure & more

Nvidia surged over 7% after Q2 results beat on both lines, with adjusted EPS of $2.22 vs $2.10 consensus and revenue of $96.22B vs $92.17B, alongside a Q3 revenue outlook of ~$108B (above estimates). Dollar General climbed ~12% after raising full-year profit guidance to $7.80–$8.00/share and signaling additional buybacks in 2H FY2027. In software/security, Salesforce rose nearly 12% on strong Q2 results and Okta gained over 19% after beating expectations and lifting full-year guidance, while HP fell nearly 11% despite beating quarterly results on a weaker reaction to full-year guidance.

Analysis

NVDA’s print is the cleanest signal in the tape: it implies the AI capex cycle is still accelerating, not merely normalizing. The second-order winners are the infrastructure bottlenecks with operating leverage to shipment mix and power density — networking, memory, foundry, and cooling/power names — while the losers are application-layer software vendors whose AI monetization is still lagging the spend curve. If NVDA keeps its forward guide intact for the next 1-2 quarters, semis leadership can persist for months; if margins or order cadence soften, the entire AI complex can re-rate down quickly.

The cyber beats in CRM/OKTA/CRWD are less about absolute growth and more about budget priority: security remains one of the few line items that gets funded even in a choppy enterprise backdrop. That supports a near-term squeeze in crowded shorts, but the durability test is billings, RPO, and net retention over the next 1-2 earnings cycles; EPS beats alone rarely sustain these gaps. Contrarian read: the market may be extrapolating multiple expansion off easier comps and lighter positioning rather than a true step-up in demand.

DG’s upside revision reads like a trade-down signal, which is bullish for the discounter cohort and negative for mid-tier discretionary/price-point fragile retailers. HPQ’s weakness is the opposite message: PCs are still not giving enough fundamental improvement to justify fresh multiple upside, so the market is punishing any name where the cycle story has already been priced. ANF looks increasingly crowded — after a large run, the first downgrade often marks the point where good news stops mattering and the stock starts trading on estimate fatigue instead of momentum.

Key Decisions for Investors

• Buy NVDA on any post-gap pullback; if you want cleaner relative value, express it as long NVDA / short HPQ for 1-3 months. Falsify if NVDA gives back the post-earnings gap and management commentary turns to margin or order deceleration.
• Add to CRWD on weakness, but only with a 1-2 quarter horizon; use a smaller size than NVDA because the move may be mostly a positioning squeeze. Falsify if next quarter billings/RPO fail to confirm the guide raise.
• Sell ANF upside via a call spread or short on strength over the next 2-4 weeks. Risk/reward is attractive because the stock already priced in a lot of estimate revision momentum; cover if it can hold the prior gap and digest the downgrade without giving back gains.
• Buy DG as a trade-down beneficiary for the next 1-3 months, but keep it tactical; the catalyst is continued stress in the low-income consumer, not a structural rerating. Falsify if management commentary starts pointing to margin pressure from pricing or if traffic trends roll over.
• Stay away from chasing CRM/OKTA at the open; wait for the first pullback to see whether the move was a squeeze or a true re-acceleration. If the stocks fade while the market opens, that is the more actionable short signal than the initial gap.